Biocon receives approval of its ANDA for Posaconazole Delayed-Release tablets from the US FDA
Biocon Pharma Limited, a subsidiary of Biocon Limited, received approval of its ANDA for Posaconazole Delayed-Release ...
Read more
Tag: ANDA
Glenmark Pharmaceuticals receives ANDA approval for Diltiazem Hydrochloride Extended-Release Capsules USP, 60 mg, 90 mg, and 120 mg: Granted competitive generic therapy (CGT) designation and is eligible for 180 days of CGT exclusivity
Glenmark Pharmaceuticals Limited (Glenmark) has received final approval by the United States Food & Drug Administration ...
Read more